The CDC Owes Parents Better Messaging on the Vaccine for Kids | WIRED
""A slide presented during the meeting showed that 0.3 percent of 12- to 25-year-olds (which of course includes 12- to 17-year-olds) have landed in the emergency room following vaccination (0.1 percent after the first dose, and 0.2 percent after the second dose). And 0.3 percent of 1 million, the total number of vaccinations in Walensky’s model, is 3,000. In other words, the CDC is suggesting that within this group, it is preferable for 3,000 12- to 17-year-olds to go to the emergency room after getting vaccinated than for 200 12- to 17-year-olds to be hospitalized from Covid-19. (It’s worth noting that visiting the emergency department is not the same as a hospital admission, and perhaps some portion of the visits were unrelated to the vaccine, but even if 90 percent of the ER patients weren’t admitted, that still would equate to 300 admissions, more than the 200 for Covid-19 infection.) Moreover, as two peer-reviewed studies in a journal published by the American Academy of Pediatrics found, at least 40 percent of pediatric Covid-19 hospitalizations were for patients in the hospital merely with Covid-19, not from Covid-19, meaning the 200 hospitalizations Walensky is referencing may really be around 120.""
""There also is a highly relevant factor that was left out of Walensky’s cost-benefit analysis. According to the CDC’s own data, 70 percent of 12- to 17-year-olds hospitalized for Covid-19 had underlying medical conditions. Whereas the evidence suggests the majority of young males with post-vaccination myocarditis were otherwise healthy. This detail matters, since it changes the risk calculation on an individual level. The risk-benefit for a 14-year-old girl with underlying conditions (putting her at higher risk for severe Covid) to be vaccinated, for example, is very different from that of a 14-year-old boy with no underlying conditions.
Further to this point, a slide in the committee meeting recommended that even if someone gets myocarditis following the first dose of the mRNA vaccine, if their heart recovers they should still consider getting a second dose. While some policy professionals were pleased with this advice, numerous cardiologists and other medical professionals condemned it. Venk Murthy, a cardiologist at the University of Michigan, commented: “In essentially no circumstances should a patient with myocarditis soon after first mRNA vax dose get a second dose, even if the heart recovers. The CDC got this wrong.” Physicians at three different major university hospitals in New York and California, who were not authorized to speak publicly, each told me this advice was “insane.”
The medical establishment has also fallen in line behind the CDC to back its questionable messaging. In a remarkable show of uniformity, a joint statement, cosigned by the heads of the CDC, the American Academy of Pediatrics, the American Heart Association, the American Medical Association, the American Nurses Association, the American Hospital Association, and 11 other national medical organizations, was released in reaction to the advisory committee meeting. It reads, in part:
Today, the CDC Advisory Committee on Immunization Practices (ACIP) met to discuss the latest data on reports of mild cases of inflammation of the heart muscle and surrounding tissue called myocarditis and pericarditis following Covid-19 vaccination among younger people.
The facts are clear: We know that myocarditis and pericarditis are much more common if you get Covid-19, and the risks to the heart from Covid-19 infection can be more severe.
We recommend getting vaccinated right away if you haven’t yet.
Several cardiologists and a pediatric immunologist I spoke with said there is no clear or definitive data they are aware of that myocarditis stemming from Covid-19 is likely to be more severe or common than it is from vaccination, particularly for healthy young people. Multiple messages to the CDC asking for the underlying data that this statement is based on went unreturned.""
COVID-19 Case Data in Israel: A Troubling Trend?